In this study, the significantly kinase targets of CDH23 included CDK1 and CDK2, which indicated that CDH23 may play key roles in DLBCL via interaction with CDK1 and CDK2, especially through the regulation of cell cycle and unscheduled proliferation. The gene discussed is CDK2; the disease is diffuse large B-cell lymphoma.